-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Ontogeny and Inherited Myeloid Disorders

Program: Scientific Program
Session: Joint Session: Ontogeny and Myeloid Disorders of Childhood
Saturday, December 9, 2023, 4:00 PM-5:35 PM

Alan B. Cantor, MD, PhD

Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Disclosures: Cantor: Cellarity, Inc.: Consultancy.

See more of: Joint Session: Ontogeny and Myeloid Disorders of Childhood
See more of: Scientific Program
<< Previous Presentation | Next Presentation >>